Search Results 51-60 of 16422 for Chronic Lymphocytic Leukemia

  1. Non-Hodgkin's lymphoma - Symptoms and causes - Mayo Clinic

    Learn more about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes ... Chronic lymphocytic leukemia ...

  2. Household Controls for Clinical and Epidemiological Studies in Lymphoma and Chronic Lymphocytic Leukemia

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. Participation eligibility. Participant eligibility ...

  3. Leukemia Clinical Trials

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  4. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia that has returned or is resistant to treatment. Participation eligibility. Participant eligibility includes age, gender, type ...

  5. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Giving pembrolizumab alone or with idelalisib or ibrutinib may be an effective treatment in patients with chronic lymphocytic leukemia or other low-grade B-cell ...

  6. Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia - Mayo Clinic

    Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia.

  7. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Diagnosis of chronic lymphocytic leukemia (CLL) according to the National Cancer Institute (NCI) criteria or small lymphocytic lymphoma (SLL) according to ...

  8. Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

    ... lymphocytes. Previous research has shown that MBL is a precursor to a type of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL).

  9. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second ...

  10. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    ... chronic lymphocytic leukemia or small lymphocytic lymphoma. Ibrutinib may ... chronic lymphocytic leukemia or small lymphocytic lymphoma. Participation ...